Abstract
The current mainstream in cancer research favours the idea that malignant tumour initiation is the result of a genetic mutation. Tumour development and progression is then explained as a sort of micro-evolutionary process, whereby an initial genetic alteration leads to abnormal proliferation of a single cell that leads to a population of clonally derived cells. It is widely claimed that tumour progression is driven by natural selection, based on the assumption that the initial tumour cells acquire some properties that endow such cells with a selective advantage over the normal cells from which the tumour cells are derived. The standard view assumes that the transformed bodily cell somehow acquires "responsiveness" to natural selection independently of the whole organism to which the cell belongs. Yet, it is never explained where such an acquired capacity to respond to natural selection by the individual bodily cell comes from. This situation poses many difficult questions that so far have been left unanswered. For example, there is no explanation why some cells belonging to an organised whole and as such having no independent capacity for survival, apparently become 'independent' entities, able to respond to selective pressures in an autonomous fashion and then to be evaluated by natural selection. Hereunder it is argued that such a qualitative change cannot be the consequence of specific genetic mutations. Moreover, it is shown that natural selection is unlikely to be acting within the organism during tumour development and progression and that tumour evolution is a random, non-adaptive process, driven by no fundamental biological principle. Thus, mutations in the so-called oncogenes and tumour suppressor genes observed in epithelial cancers (that constitute more than 90% of all cancers) are not the result of selection for better cellular growth or survival under restrictive conditions. Instead, here it is suggested that they are the consequence of genetic drift acting upon gene functions that become non-relevant, either for the individual or the species fitness, once the organism is past its reproductive prime and as such, they also become superfluous for cell survival in the short term. It is proposed that the origin of cancer is epigenetic and it is a consequence of the need for a continued turnover of the individuals that constitute a species.
Similar content being viewed by others
REFERENCES
Alberts, B., D. Bray, J. Lewis, M. Raff, K. Roberts and J.D. Watson (1989). Molecular Biology of the Cell, 2nd ed., pp. 1187-1203. Garland, New York.
Alberts, B., D. Bray, J. Lewis, M. Raff, K. Roberts and J.D. Watson (1994). Molecular Biology of The Cell, 3rd ed., pp. 1255-1294. Garland, New York.
Alizadeh, A.A., M.B. Eisen, R.E. Davis, C. Ma, I.S. Lossos, A. Rosenwald, J.C. Boldrick, H. Sabet, T. Tran, X. Yu, J.I. Powell, L. Yang, G.E. Marti, T. Moore, J. Hudson, L. Lu, D.B. Lewis, R. Tibshirani, G. Sherlock, W.C. Chan, T.C. Greiner, D.D. Weisenburger, J.O. Armitage, R. Warnke, R. Levy, W. Wilson, M.R. Grever, J.C. Byrd, D. Botstein, P.O. Brown and L.M. Staudt (2000). Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403: 503-511.
American Cancer Society (2000). Cancer Facts and Figures, pp.1-7. American Cancer Society, Atlanta.
Aranda-Anzaldo, A. (1989). On the role of chromatin higher-order structure and mechanical interactions in the regulation of gene expression. Speculations in Science and Technology 12: 163-176.
Aranda-Anzaldo, A. (1990). Higher-order structure in the cell nucleus and embryonic development. Speculations in Science and Technology 13: 53-59.
Aranda-Anzaldo, A. (1993). A role for the nucleotype in the pathogenesis of primary hepatocellular carcinoma. Medical Hypotheses 40: 207-210.
Aranda-Anzaldo, A. (1997). The gene as the unit of selection: a case of evolutive delusion. Ludus Vitalis V(9): 91-120.
Aranda-Anzaldo, A., F. Orozco-Velasco, E. García-Villa and P. Gariglio (1999). p53 is a rate-limiting factor in the repair of higher-order DNA structure. Biochimica et Biophysica Acta 1446(3): 181-192.
Armstrong, J., M.H. Kaufman, D.J. Harrison and A.R. Clarke (1995). High frequency developmental abnormalities in p53-deficient mice. Current Biology 5: 931-936.
Artandi, S.E., S. Chang, S-L. Lee, S. Alson, G.J. Gottlieb and R.A. DePinho (2000). Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406: 641-645.
Bialy, H. (1998). Aneuploidy and cancer: vintage wine in a new bottle? Nature Biotechnology 16: 137-138.
Bishop J.M. (1991). Molecular themes in oncogenesis. Cell 64: 235-248.
Blasco, M.A., H-W. Lee, P.M. Hande, E. Samper, P.M. Lansdorp, R.A. DePinho and C.W. Greider (1997). Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91: 25-34.
Boveri, T. (1914). Zur Frage der Enstehung Maligner Tumoren. Gustav Fischer Verlag, Jena.
Brandon, R.N. (1999). The units of selection revisited: the modules of selection. Biology and Philosophy 14: 167-180.
Burnet, F.M. (1957). Cancer: a biological approach. British Medical Journal 1: 779-786; 841–847.
Burnet, F.M. (1974). Intrinsic Mutagenesis: a genetic approach to ageing. MTP Ltd, Lancaster.
Cahill, D.P., C. Lengauer, J. Yu, G.J. Riggins, J.K.V. Willson, S.D. Markowitz, K.W. Kinzler and B. Vogelstein (1998). Mutations of mitotic checkpoint genes in human cancers. Nature 392: 300-303.
Cairns, J. (1975). Mutation selection and the natural history of cancer. Nature 255: 197-200.
Callebaut, W. (1995). The future of naturalistic philosophy of science. Ludus Vitalis III(5): 19-52.
Charlesworth, B. (1994). How does increased fitness evolve? Current Biology 4: 1146-1148.
Charlesworth, B. (1996). Evolution of senescence: Alzheimer's disease and evolution. Current Biology 6: 20-22.
Clurman, B. and M. Groudine (1997). Killer in search of a motive? Nature 389: 122-123.
Cooper, G.M. (1997). The Cell: a molecular approach, pp 599-608. Sinauer-ASM Press, Sunderland, Mass.
Curtis, H. and C. Crowley (1963). Chromosome aberrations in liver cells in relation to the somatic mutation theory of ageing. Radiation Research 19: 337-344.
Davidov, M. (1999). Genetic stability: the key to longevity? Medical Hypotheses 53: 329-332.
de Lange, T. (1992). Human telomeres are attached to the nuclear matrix. EMBO Journal 11: 717-724.
de Lange, T. (1998). Telomeres and senescence: ending the debate. Science 279: 334-335.
Doll, R. and R. Peto (1987). Epidemiology of cancer. In: D.J. Weatherall, J.G.G. Ledingham and D.A. Warrell (eds.), Oxford Textbook of Medicine, 2nd ed., pp. 4.95-4.123. Oxford University Press, Oxford.
Drake, J.W. (1969). Comparative rates of spontaneous mutation. Nature 221: 1132.
Duesberg, P.H. (1987). Retroviruses as carcinogens and pathogens: expectations and reality. Cancer Research 47: 1199-1206.
Duesberg, P.H. (1995). Oncogenes and Cancer. Science 267: 407-408.
Fearon, E.R. and B. Vogelstein (1990). A genetic model for colorectal tumorigenesis. Cell 61: 759-767.
Fearon, E.R. (1999). Cancer progression. Current Biology 9: R873-R875.
Feltz, B. (1992). Auto-organisation, développement et théories de l'evolution. Uroboros II(1): 105-126.
Franks, L.M. (1991). What is cancer?. In: L.M. Franks and N.M. Teich (eds.), Introduction to the cellular and molecular biology of cancer, 2nd ed., pp. 7-9. Oxford University Press, Oxford.
Frei, E. (1993). Pathobiology of cancer. In: E. Rubinstein and D.D. Federman (eds.), Scientific American Medicine, 12(III): 18-20. Scientific American, New York.
Friedberg, E.C. (1985). DNA Repair. p 8. W.H. Freeman, San Francisco.
Goldrath, A.W. and M.J. Bevan (1999). Selecting and maintaining a diverse T-cell repertoire. Nature 402: 255-262.
Hahn, W.C., C.M. Counter, A.S. Lundberg, R.L. Beijersbergen, M.W. Brooks and R.A. Weinberg (1999). Creation of human tumour cells with defined genetic elements. Nature 399: 464-468.
Hall, P.A. and D.P. Lane (1997). Tumour suppressors: a developing role for p53? Current Biology 7: R144-R174.
Hamilton, W.D. (1966). The moulding of senescence by natural selection. Journal of Theoretical Biology 12: 12-45.
Harley, C., A. Futcher and C. Greider (1990). Telomeres shorten during ageing of human fibroblasts. Nature 345: 458-460.
Hayflick, L. (2000). The future of ageing. Nature 408: 267-269.
Hollstein, M., D. Sidranski, B. Vogelstein and C.C. Harris (1991). p53 mutations in human cancers. Science 253: 49-53.
Hua, V.Y., W.K. Wang and P.H. Duesberg (1997). Dominant transformation by mutated ras genes in vitro requires more than 100 times higher expression than is observed in cancers. Proceedings of the National Academy of Sciences USA 94: 9614-9619.
Ilyas, M., J. Straub, I.P. Tomlinson and W.F. Bodmer (1999). Genetic pathways in colorectal and other cancers. European Journal of Cancer 35: 335-351.
Janeway, C.A. and P. Travers (1994). Immunobiology; the immune system in health and disease, Ch. 11: 36-45. Current Biology Ltd, London/Garland Publishing Inc., New York/Blackwell Scientific Publications, Oxford.
Jen, J., S.M. Powell, N. Papadopoulos, K.J. Smith, S.R. Hamilton, B. Vogelstein and K.W. Kinzler (1994). Molecular determinants of dysplasia in colorectal lesions. Cancer Research 54: 5523-5526.
Kinzler, K.W. and B. Vogelstein (1997). Gatekeepers and caretakers. Nature 386: 761-763.
Land, H., L.F. Parada and R.A. Weinberg (1983). Cellular oncogenes and multistep carcinogenesis. Science 222: 771-778.
Lane, D.P. (1992). Worrying about p53. Current Biology 2: 581-583.
Lengauer, C., K.W. Kinzler and B. Vogelstein (1997). Genetic instability in colorectal cancers. Nature 386: 616-620
Lewin, B. (2000). Genes VII. Oxford, Oxford University Press.
Li, R., G. Yerganian, P. Duesberg, A. Kraemer, A. Willer, C. Rausch and R. Hehelmann (1997). Aneuploidy correlated 100% with chemical transformation of Chinese hamster cells. Proceedings of the National Academy of Sciences USA 94: 14506-14511.
Li, R., A. Sonik, R. Stindl, D. Rasnick and P. Duesberg (2000). Aneuploidy vs. gene mutation hypothesis of cancer: recent study claims mutation but is found to support aneuploidy. Proceedings of the National Academy of Sciences USA 97: 3236-3241.
Loeb, L.A. (1991). Mutator phenotype may be required for multistage carcinogenesis. Cancer Research 51: 3075-79.
Loeb, L.A. (1997). Transient expression of a mutator phenotype in cancer cells. Science 277: 1449-1450.
Ly, D. H., D.J. Lockhart, R.A. Lerner and P.G. Schultz. (2000). Mitotic misregulation and human ageing. Science 287: 2486-2492.
Marshall, C.J. (1991). Tumor suppressor genes. Cell 64: 313-326.
Matsudara, P., A. Berk, S.L. Zipursky, D. Baltimore, J. Darnell and H. Lodish (2000). Molecular Cell Biology 4th ed., p. 1055. W.H. Freeman, New York.
Mayr, E. (1988). Toward a New Philosophy of Biology, p. 17. Harvard University Press, Cambridge, Massachusetts.
Nathan, D.M. (1993). Diabetes mellitus. In: E. Rubinstein and D.D. Federman (eds.), Scientific American Medicine, 9(VI): 1-27. Scientific American, New York.
Nowell, P.C. (1976). The clonal evolution of tumor cell populations. Science 194: 23-28.
Pennisi, E. (1997). New tumor suppressor found twice. Science 275: 1876-1878.
Perou, C.M., T. Sorlie, M.B. Eisen, M. van de Rijn, S.S. Jeffrey, C.A. Rees, J.R. Pollack, D.T. Ross, H. Johnsen, L.A. Akslen, O. Fluge, A. Pergamenschikov, C. Williams, S.X. Zhu, P.E. Lonning, A.-L. Borresen-Dale, P.O. Brown and D. Botstein (2000). Molecular portraits of human breast tumours. Nature 406: 747-752.
Pienta, K.J. and D.S. Coffey (1991). Cellular harmonic information transfer through a tissue tensegrity-matrix system. Medical Hypotheses 34: 88-95.
Rasnick D. and P. Duesberg (1999). How aneuploidy affects metabolic control and causes cancer. Biochemical Journal 340: 621-630.
Razin, S.V., I.I. Gromova and O.V. Iarovaia (1995). Specificity and functional significance of DNA interaction with the nuclear matrix: new approaches to clarify old questions. International Review of Cytology 162B: 405-49.
Richards, B., H. Zhang, G. Phera and M. Meuth (1997). Conditional mutator phenotypes in hMSH2-deficient tumor cell lines. Science 277: 1523-1526.
Risch, N., E.W. Reich, M.M. Wishnick and J.G. McCarthy (1987). Spontaneous mutation and parental age in humans. American Journal of Human Genetics 41: 218-248.
Robbins, S.L., R.S. Cotran and V. Kumar (1989). Pathological Basis of Disease, 4th edn, pp.239-305. WB Saunders, Philadelphia.
Routtenberg, A. (1995). Knockout mouse fault lines. Nature 374: 315.
Ruddon, R.H. (1981). Cancer Biology. Oxford University Press, Oxford.
Sniegowski, P.D., P.J. Gerrish and R.E. Lenski (1997). Evolution of high mutation rates in experimental populations of E. coli. Nature 387: 700-702.
Sober, E. (1984). The Nature of Selection. MIT Press, Boston.
Srivastava, S, Y. Tong, K. Devadas, Z. Zou, V. Sykes, Y. Chen, W. Blattner, K. Pirrollo and E. Chang (1992). Detection of both mutant and wild-type p53 proteins in normal skin fibroblasts and demostration of a shared ‘second hit’ on p53 in diverse tumors from a cancer-prone family with Li-Fraumeni syndrome. Oncogene 7: 987-991.
Tomlinson, I. and W. Bodmer (1999). Selection, the mutation rate and cancer: ensuring that the tail does not wag the dog. Nature Medicine 5: 11-12.
Visser, A.E., F. Jaunin, S. Fakan and J.A. Aten (2000). High resolution analysis of interphase chromosme domains. Journal of Cell Science 113: 2585-2593.
Vogelstein, B. and K. Kinzler (1996). Lessons from hereditary colorectal cancer. Cell 87: 159-170.
Waddington, C.H. (1968). The theory of evolution today. In: A. Koestler and J.R. Smythies (eds.), Beyond Reductionism, pp. 357-395. Hutchinson, London.
Watson, J.D., M. Gilman, J. Witkowski and M. Zoller (1992). Recombinant DNA, 2nd ed, p.336, Freeman-Scientific American Books, New York.
Weinberg, R.A. (1993). Molecular mechanisms of carcinogenesis. In: E. Rubinstein and D.D. Federman (eds.), Scientific American Medicine, 12(II): 1-14. Scientific American, New York.
Weisbuch, G. (1989). Dynamique des systemes complexes. InterEditions/Editions de CNRS, Paris.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Aranda-Anzaldo, A. Cancer Development and Progression: A Non-Adaptive Process Driven by Genetic Drift. Acta Biotheor 49, 89–108 (2001). https://doi.org/10.1023/A:1010215424196
Issue Date:
DOI: https://doi.org/10.1023/A:1010215424196